None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Male and female subjects having Age more than 18 -50 years with at least 1/3 darkly pigmentation 2. Subjects with BMI 18.5-30 3. Subjects wrist size for Female :5.5ââ?¬•to 6.5ââ?¬• and Male :6.5-7.5ââ?¬• 4. (Carboxyhemoglobin) Co value ââ?°Â¤2.0% FCOHb 5. Hemoglobin value is greater than or equal to 11g/dL 6. Baseline heart rate ââ?°Â¥45bpm and ââ?°Â¤85bpm. 7. Subject is willing to give written informed consent 8. Subject is willing and able to comply with all trial requirements 9. A negative pregnancy test result in women of childbearing potential.
Exclusion criteria
Exclusion criteria: 1.The subject is obese (BMI is greater than 30). 2.The subject has a known history of heart disease, lung disease, kidney or liver disease. 3.Diagnosis of asthma, sleep apnea, or use of CPAP. 4.Subject has diabetes. 5.Subject has a clotting disorder. 6.The subject a hemoglobinopathy or history of anemia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ââ???Calibrate and Validate the wrist based noninvasive SpO2 measurement tracker to measure SpO2 ranges (100-97, 97-92, 92-85, 84-78) during hand motion in in comparison to I.Goldââ?¬?standardââ?¬? measurements of blood SaO2 by a CO ââ?¬? OXIMETER II.In comparison to hospital grade pulse oximeter III. In comparison to Over the counter pulse oximeter Timepoint: SpO2 ranges (100-97, 97-92, 92-85, 84-78)- one time use | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Means for delivering medical-grade oxyg/en-nitrogen mixtures of varying fractional inspired oxygen (FiO2) levels. 2. To evaluate safety and performance of device Timepoint: SpO2 ranges (100-97, 97-92, 92-85, 84-78) one time use | — |
Countries
India
Contacts
ICBio Clinical Research Pvt. Ltd.